COSTS ASSOCIATED WITH TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY PROGRESSION

被引:1
|
作者
Ines, M. [1 ]
Coelho, T. [2 ]
Conceicao, I [3 ]
Borges, M. [4 ]
Carvalho, M. [5 ]
Costa, J. [6 ]
机构
[1] Inst Med Mol, Lisbon, Portugal
[2] Hosp Santo Antonio, Unidade Clin Paramiloidose, Oporto, Portugal
[3] Hosp Santa Maria, Ctr Hosp Lisboa Norte, Lisbon, Portugal
[4] Univ Lisbon, Fac Med, Ctr Evidence Based Med, Lisbon, Portugal
[5] Ctr Hosp Lisboa Norte, Lisbon, Portugal
[6] Univ Lisbon, Fac Med, Lab Clin Pharmacol & Therapeut, Lisbon, Portugal
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PSY54
引用
收藏
页码:A553 / A554
页数:2
相关论文
共 50 条
  • [41] FAMILIAL AMYLOID POLYNEUROPATHY ASSOCIATED WITH THE TRANSTHYRETIN CYS114 GENE IN A JAPANESE KINDRED
    UENO, S
    FUJIMURA, H
    YORIFUJI, S
    NAKAMURA, Y
    TAKAHASHI, M
    TARUI, S
    YANAGIHARA, T
    BRAIN, 1992, 115 : 1275 - 1289
  • [42] Epidemiology of Transthyretin Familial Amyloid Polyneuropathy in Portugal: A Nationwide Study
    Ines, Monica
    Coelho, Teresa
    Conceicao, Isabel
    Duarte-Ramos, Filipa
    de Carvalho, Mamede
    Costa, Joao
    NEUROEPIDEMIOLOGY, 2018, 51 (3-4) : 177 - 182
  • [43] Recommendations regarding diagnosis and treatment of transthyretin familial amyloid polyneuropathy
    Garcia-Pavia, Pablo
    Munoz-Beamud, Francisco
    Casasnovas, Carlos
    MEDICINA CLINICA, 2015, 145 (05): : 211 - 217
  • [44] Liver transplantation in transthyretin-related familial amyloid polyneuropathy
    Stangou, AJ
    Hawkins, PN
    CURRENT OPINION IN NEUROLOGY, 2004, 17 (05) : 615 - 620
  • [45] Current and Future Treatment Approaches in Transthyretin Familial Amyloid Polyneuropathy
    Kerschen, Philippe
    Plante-Bordeneuve, Violaine
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2016, 18 (12)
  • [46] Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy
    Schmidt, Hartmut H-J.
    Barroso, Fabio
    Gonzalez-Duarte, Alejandra
    Conceicao, Isabel
    Obici, Laura
    Keohane, Denis
    Amass, Leslie
    MUSCLE & NERVE, 2016, 54 (03) : 353 - 360
  • [47] Ocular manifestations of transthyretin-related familial amyloid polyneuropathy
    Antoine Rousseau
    Emmanuel Barreau
    Julia Meney
    Zoia Mincheva
    Cécile Cauquil
    Marie Théaudin
    Marc Labetoulle
    David Adams
    Orphanet Journal of Rare Diseases, 10 (Suppl 1)
  • [48] INFLUENCE OF BASELINE NEUROLOGIC SEVERITY ON DISEASE PROGRESSION AND THE ASSOCIATED DISEASE-MODIFYING EFFECTS OF TAFAMIDIS IN TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY
    Amass, L.
    Li, H.
    Gundapaneni, B.
    Schwartz, J.
    Keohane, D.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2017, 22 (03) : 235 - 235
  • [49] Current and Future Treatment Approaches in Transthyretin Familial Amyloid Polyneuropathy
    Philippe Kerschen
    Violaine Planté-Bordeneuve
    Current Treatment Options in Neurology, 2016, 18
  • [50] AMBULATORY MEDICINES COST WITH TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY IN PORTUGAL
    Ines, M.
    Coelho, T.
    Conceicao, I
    Mourao, A.
    Carvalho, M.
    Costa, J.
    VALUE IN HEALTH, 2015, 18 (07) : A667 - A667